Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

• Status: Completed
• Trial end date: 2006-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary purpose of this study is to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Utrecht Institute for Pharmaceutical Sciences
• Treatments: Methylphenidate

Criteria

Inclusion Criteria:

• adult ADHD patient over 21 years old

• valid driver's license for at least 3 years

• treated with methylphenidate

• written informed consent

Exclusion Criteria:

• use of illicit drugs

• use of drugs or having medical conditions known to affect driving ability